Banque Pictet & Cie Sa Apellis Pharmaceuticals, Inc. Transaction History

Banque Pictet & Cie Sa

$14.9 Billion
Q4 2024

A detailed history of Banque Pictet & Cie Sa transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 97,299 shares of APLS stock, worth $2.86 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

97,299

Previous 73,883 31.69%

Holding current value

$2.86 Million

Previous $2.13 Million 45.73%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$26.18 - $35.42 $613,030 - $829,394	23,416 Added 31.69%	97,299 $3.1 Million
Q3 2024 Oct 21, 2024	BUY	$28.84 - $41.15 $2.13 Million - $3.04 Million	73,883 New	73,883 $2.13 Million
Q3 2023 Nov 02, 2023	SELL	$23.65 - $89.22 $115,719 - $436,553	-4,893 Reduced 4.57%	102,242 $3.89 Million
Q2 2023 Aug 04, 2023	SELL	$76.68 - $93.31 $2.41 Million - $2.94 Million	-31,467 Reduced 22.7%	107,135 $9.76 Million
Q1 2023 May 01, 2023	SELL	$46.59 - $66.96 $946,848 - $1.36 Million	-20,323 Reduced 12.79%	138,602 $9.14 Million
Q4 2022 Feb 06, 2023	SELL	$43.24 - $61.04 $434,389 - $613,207	-10,046 Reduced 5.95%	158,925 $0
Q3 2022 Nov 10, 2022	SELL	$44.76 - $69.66 $473,516 - $736,933	-10,579 Reduced 5.89%	168,971 $11.5 Billion
Q2 2022 Aug 08, 2022	SELL	$35.07 - $59.21 $339,232 - $572,738	-9,673 Reduced 5.11%	179,550 $8.12 Million
Q1 2022 May 04, 2022	BUY	$35.46 - $54.12 $735,227 - $1.12 Million	20,734 Added 12.31%	189,223 $9.61 Million
Q4 2021 Feb 02, 2022	BUY	$30.74 - $49.16 $4.66 Million - $7.45 Million	151,606 Added 897.98%	168,489 $7.97 Million
Q3 2021 Nov 10, 2021	SELL	$31.4 - $69.84 $180,298 - $401,021	-5,742 Reduced 25.38%	16,883 $556,000
Q2 2021 Aug 12, 2021	BUY	$40.9 - $64.9 $42,822 - $67,950	1,047 Added 4.85%	22,625 $1.43 Million
Q1 2021 May 11, 2021	BUY	$40.8 - $57.39 $880,382 - $1.24 Million	21,578 New	21,578 $926,000

Others Institutions Holding APLS

# of Institutions

303

Shares Held

112M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Apellis Pharmaceuticals, Inc. Transaction History